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SINDROM KORONARI AKUT DI KALANGAN PESAKIT MUDA DI HOSPITAL 
UNIVERSITI SAINS MALAYSIA DAN FAKTOR-FAKTOR BERKAITAN 
DENGAN KOMPLIKASI 
 
ABSTRAK 
 
Penyakit vaskular koronari adalah punca utama mortaliti dan morbiditi di Malaysia. Pada 
tahun 2006, anggaran insiden sindrom koronari akut (SKA) di Malaysia adalah 141 per 
100,000 penduduk dan kadar kematian pesakit di hospital adalah kira-kira 7%. Walaupun 
SKA berlaku kebanyakannya di kalangan pesakit yang tua, kira-kira 5 hingga 10% daripada 
kes-kes yang berlaku adalah pesakit muda yang berumur kurang daripada 45 tahun yang 
boleh mengakibatkan morbiditi yang tinggi dan menjejaskan kualiti hidup pada peringkat 
kehidupan yang paling produktif. Kajian ke atas SKA di kalangan pesakit muda di Malaysia 
adalah terhad dan hasil kajian ini diharap dapat digunapakai untuk rujukan dan penyelidikan 
untuk manfaat pesakit. Kajian ini bertujuan untuk mengenal pasti ciri-ciri, rawatan dan 
komplikasi SKA di kalangan pesakit muda yang berumur kurang daripada 45 tahun yang 
dimasukkan ke Hospital Universiti Sains Malaysia (HUSM) dan faktor-faktor yang 
berkaitan dengan komplikasi. Kajian ini merupakan tinjauan rekod retrospektif. Pesakit 
muda yang berumur kurang daripada 45 tahun yang disahkan menghidap SKA dan 
dimasukkan ke HUSM di antara 1 Januari 2002 hingga 31 Disember 2012 yang memenuhi 
kriteria penyertaan dan pengecualian telah dimasukkan ke dalam kajian ini. Maklumat data 
dikumpul dengan menggunakan senarai semak yang direka oleh penyelidik terdiri daripada 
sosiodemografi, sejarah perubatan, persembahan klinikal, penyiasatan  makmal dan 
diagnosis, rawatan dan komplikasi. Logistik regresi mudah dan berganda telah digunakan 
untuk analisis data. Seramai 147 pesakit telah dimasukkan dalam kajian, dengan min 
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(sisihan piawai) umur 39.1 (4.97) tahun dan nisbah lelaki kepada perempuan adalah 3:1. 
Daripada semua pesakit, 64.6% telah disahkan sebagai angina tidak stabil, 15.6% sebagai 
tidak elevasi ST infaksi miokardium dan 19.7% elevasi ST infaksi miokardium. Faktor 
risiko yang paling kerap adalah dislipidemia (65.3%), diikuti oleh hipertensi (43.5%), 
sedang merokok (42.9%) dan penyakit jantung (29.9%). Kebanyakan pesakit dirawat 
dengan ubatan dengan 91.8% menerima aspirin dan statin, dan 86.4% menerima clopidogrel 
manakala streptokinase diberikan kepada 11.6%, heparin kepada 6.3% dan fondaparinux 
kepada 52.4%. Terdapat 73 pesakit (49.7%) mempunyai komplikasi SKA dengan 
komplikasi yang paling kerap ialah kegagalan fungsi jantung (35.4%) diikuti oleh aritmia 
(20.4%) dan paru-paru bengkak dan kejutan kardiogenik (kedua-duanya dalam 13.6%). 
Perokok [nisbah odd terselaras (NOT) 4.03; 95% julat keyakinan (JK) 1.33, 12.23; nilai p= 
0.014], kencing manis [NOT 3.03; 95% JK 1.19, 7.71; nilai p= 0.020], dan rawatan 
farmakologi menggunakan fondaparinux [NOT 0.18; 95 % JK  0.08, 0.39, nilai p < 0,001] 
dan nitrat oral [NOT 0.18; 95% JK 0.08, 0.42; nilai p < 0.001] adalah faktor yang bererti 
untuk mendapat komplikasi SKA di kalangan pesakit muda yang dimasukkan di HUSM 
apabila pembolehubah lain dikawal. Kesimpulannya, terdapat prevalens yang tinggi bagi 
faktor risiko kardiovaskular, yang menunjukkan pentingnya program pencegahan primer. 
Kebanyakan pesakit dirawat dengan ubatan dan kegagalan fungsi jantung adalah komplikasi 
yang paling kerap berlaku. Status merokok dan kencing manis merupakan faktor risiko 
manakala rawatan farmakologi menggunakan fondaparinux dan oral nitrat merupakan 
faktor pelindung yang bererti untuk komplikasi SKA dikalangan pesakit muda yang 
dimasukkan ke HUSM. 
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ABSTRACT 
 
Coronary vascular diseases are the main causes of mortality and morbidity in Malaysia. In 
year 2006, the estimated incidence of acute coronary syndrome (ACS) in Malaysia was 141 
per 100,000 population, and the inpatient mortality rate was approximately 7%. Although 
ACS occurs mainly in older patients, about 5 to 10% of cases occur in young patients aged 
less than 45 years old causing considerable morbidity and affecting the quality of life in 
their most productive life. Studies on ACS in young patients in Malaysia are limited and 
thus the result of this study will hopefully applicable for further reference and research for 
the benefits of patients. This study was aimed to identify the characteristics, treatment and 
complications of ACS in young patients aged less than 45 years old admitted in Hospital 
Universiti Sains Malaysia (HUSM) and the factors associated with its complications. This 
study was a retrospective record review. Young patients aged less than 45 years old who 
diagnosed with ACS and admitted to HUSM between 1st of January 2002 to 31st of 
December 2012 who fulfilled the inclusion and exclusion criteria were included in the 
study. The data information were collected using a checklist performa designed by 
researcher consisted of socio-demography, medical history, clinical presentation, laboratory 
investigation and diagnosis, treatment and complications. Simple and Multiple logistic 
regressions were used for data analysis. A total of 147 patients were enrolled, with mean 
(standard deviation) age of 39.1 (4.97) years and male to female ratio of 3:1. Of total 
sample, 64.6% were diagnosed as unstable angina, 15.6% as non ST elevation myocardial 
infarction and 19.7% as ST elevation myocardial infarction. The most frequent risk factors 
of ACS were dyslipidaemia (65.3%), followed by hypertension (43.5%), current smoking 
(42.9%) and heart disease (29.9%). Most patients treated medically with 91.8% patients 
received aspirin and statin, and 86.4% received clopidogrel while streptokinase were 
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prescribed in 11.6% of patients, heparin in 46.3% and fondaparinux in 52.4%. There were 
73 patients (49.7%) had complication(s) of ACS with the most common were heart failure, 
(35.4%) followed by arrhythmia (20.4%) and pulmonary oedema and cardiogenic shock 
(both 13.6%). Current smokers [adjusted odds ratio (AOR) 4.03; 95% confidence interval 
(CI): 1.33, 12.23; p value = 0.014], diabetic mellitus [AOR 3.03; 95% CI: 1.19, 7.71; p 
value = 0.020], and pharmacological treatments of fondaparinux [AOR 0.18; 95% CI: 0.08, 
0.39; p value < 0.001] and oral nitrates [AOR 0.18; 95% CI: 0.08, 0.42; p value < 0.001] 
were the significant associated factors for complications of ACS in young patients admitted 
in HUSM when other variables were controlled. In conclusion, there was high prevalence of 
established cardiovascular risk factors in which indicating the importance of primary 
prevention. Most patients treated medically and heart failure was the most common 
complication. Smoking status and diabetes mellitus were the significant risk factors while 
pharmacological treatment of fondaparinux and oral nitrates were the significant protective 
factors for complications in ACS in young patients admitted in HUSM. 
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CHAPTER ONE  
INTRODUCTION 
 
1.1 Overview of Acute Coronary Syndrome (ACS) 
Cardiovascular diseases (CVDs) are the number one cause of global death. In 2008, an 
estimated 17.3 million people died from CVD and an estimated 7.3 million were due to 
Coronary Artery Diseases (CAD). Projected almost 25 million people will die from CVD, 
mainly from heart disease and stroke by 2030 and remain the single leading cause of death 
(WHO, 2012).  In the Euroheart Acute Coronary Syndrome (ACS)  survey, 23% were less 
than 55 years old (Rosengren et al., 2006). The Global Registry of Acute Coronary Events 
(GRACE) showed that 6.3% were patients less than 45 years old (Avezum et al., 2005). 
CVDs are the main causes of mortality and morbidity in Malaysia. In 2006, the estimated 
incidence of ACS was 141 per 100,000 populations per year, and the inpatient mortality rate 
was approximately 7% (Ahmad et al., 2011). In Thailand, 5.8% of patients with ACS are 
under the age of 45 years old and the risk factors in young patients differ from older group 
(Tungsubutra et al., 2007).   
 ACS refers to a spectrum of clinical presentations ranging from unstable angina (UA) 
to non ST elevation myocardial infarction (NSTEMI) and to ST elevation myocardial 
infarction (STEMI). In terms of pathology, ACS arises from atherosclerotic plaque rupture 
with subsequent coronary thrombosis and/or spasm. The resulting coronary artery occlusion 
gives rise to intense myocardial ischaemia or even myocardial necrosis (Beltrame et al., 
2012). 
  ACS has higher prevalence in middle-aged and elderly patients; thus comparatively 
few studies have focused on the clinical presentation, treatment and outcome of ACS in 
young patients. ACS causes a significant morbidity, psychological effects, and financial 
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constraints for the person and the family when it occurs at a young age. There are differences 
of characteristics between young and older patients with ACS. Young patients with ACS 
commonly presented with chest pain but rarely heart failure (Schoenenberger et al., 2011). 
Younger patients were more likely to have an STEMI (67.3%) than older group (Tungsubutra 
et al., 2007). 
 The most important cardiovascular risk factors in ACS in young patients are smoking, 
family history of CAD, dyslipidaemia and obesity (Egred et al., 2005; Tungsubutra et al., 
2007; Schoenenberger et al., 2011). Smoking is an important cardiovascular risk factor that 
inversely related to age. The prevalence of smoking was from 70 to 90% among young ACS 
patients;  and smoking was found up to 92% among young patients with reported 
atheromatous process (Egred et al., 2005). Dyslipidaemia was also highly prevalence in 
young patients. A family history of CAD, considered as one of the most important risk factor. 
The patients with family history of CAD tend to have abnormal lipid profile especially 
hypertriglyceridaemia and low HDL, insulin resistance and obesity which strengthen the 
theory of common genetic linkage (Fox et al., 2000; Egred et al., 2005; Tungsubutra et al., 
2007). 
  In young patients diagnosed with ACS, aspirin, beta-blockers, thrombolytic therapy 
and statins were all frequently prescribed. Unfractionated heparin was prescribed more often 
to the younger groups, whereas the rate of low-molecular-weight heparin (LMWH) usage 
remained relatively consistent among young and elder patients. Glycoprotein (GP) IIb/IIIa 
inhibitors were prescribed to nearly one-third of patients aged less than 45 years and their use 
decreased with advanced age. Angiotensin-converting enzyme inhibitors (ACEI) were 
prescribed more often in older patients (Avezum et al., 2005).  
  Coronary angiography and percutaneous coronary intervention (PCI) were performed 
more frequently in young ACS patients. The mortality for ACS remains high particularly in 
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STEMI. Over 75% of STEMI patients received thrombolysis or proceeded to primary 
angioplasty. Patients who missed thrombolysis were twice likely to die than those who 
received. In a study of patients who underwent PCI, the prevalence revealed higher in young 
patients less than 40 years old as compared to older patients over 60 years old. PCI reduced 
mortality in NSTEMI and UA but not in STEMI (Chin et al., 2008). 
  The cut off age of 45 years old had been used in most studies to define young 
patients with ACS and this same age also being used in this study (Avezum et al., 2005; 
Egred et al., 2005; Tungsubutra et al., 2007). In the GRACE study that involved 24165 ACS 
patients in 102 hospitals in 14 countries in Europe, North and South America, Australia and 
New Zealand in which the impact of age on the management and outcome of ACS was 
evaluated and the patients were stratified into six categories; < 45 years, 45-54, 55-64, 65-74, 
75-84 and > 85 years. The youngest group was less than 45 years old (Avezum et al., 2005). 
The Thai ACS registry, the patients were divided into three categories; < 45 years, 45-54 and 
> 54 years (Tungsubutra et al., 2007). As conclusion, in this study the patients with age of 
less than 45 years old had been defined as young patients after considering of other studies 
globally and the neibourhood countries to facilitate this study for comparison and conclusion.  
 
 
 
1.2 Rationale of the Study 
Acute coronary syndrome (ACS) is a major health problem, with relatively high morbidity 
and mortality. The occurrence of ACS in young adults will lead to premature morbidity and 
mortality in the person’s most productive years of life which also affect his or her family and 
working life. It may also affect not only physical but psychosocial of the patients.  
 Assessing the status of local setting by understanding the sociodemographic, clinical 
presentation and risk factors of ACS in young patients will provide local data that are 
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considerably useful in evaluating the effectiveness of management as well as preventive and 
control strategies and intervention for ACS. High prevalence of risk factors in ACS among 
younger age patients indicate that prevention should begin at early age. Studies on ACS in 
young patients in Malaysia are limited and thus the result of this study will be hopefully 
applicable for further reference and research for benefits of patients.  
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CHAPTER TWO  
LITERATURE REVIEW 
 
2.1 Acute Coronary Syndrome (ACS) 
Acute coronary syndromes (ACS) encompass a spectrum of coronary artery diseases, ranging 
from unstable angina (UA), non-ST elevation myocardial infarction (NSTEMI) and ST-
elevation myocardial infarction (STEMI).  The term of ACS is useful because the initial 
presentation and early management of UA, NSTEMI and STEMI are frequently similar. The 
initial assessment requires a detailed history which include risk factor analysis, a physical 
examination, an electrocardiography (ECG) and measurement of serum cardiac marker 
(Achar et al., 2005). 
 
2.1.1 Unstable Angina (UA) 
Angina is referred to any coronary heart disease syndrome resulting in myocardial ischaemia. 
The different coronary pathophysiological mechanisms may be responsible for the initiation 
of the myocardial ischaemia, including coronary artery spasm and microvascular dysfunction. 
Patients can present as exertional or rest angina, depending upon the underlying mechanism 
(Beltrame et al., 2012). Table 2.1 shows the types of angina.  
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Table 2.1: Types of Angina. Adapted from British Heart Foundation: Coronary heart disease 
  statistics 2010  (BHF, 2010) 
Angina Syndrome  Clinical Features 
Unstable Angina  1) Characterized by crescendo or rest angina  
    2) An acute coronary syndrome manifestation (may   
     progress on to myocardial infarction) 
    3) Typically due to an unstable atherosclerotic plaque 
 
Stable Angina  1) Characterized by exertional angina 
    2) Typically due to a stable but tight obstructive coronary  
     artery 
 
Prinzmetal Variant Angina 1) Characterized by rest or nocturnal angina 
    2) Typically due to coronary spasm 
 
Decubitus Angina  1) Characterized by angina when lying down 
    2) Typically due to left ventricular dysfunction resulting  
     in redistribution of pulmonary fluids and thus  
     increased cardiac workload 
 
Silent Ischaemia  1) Absence of angina in the presence of documented  
     ischaemia 
    2) May occur with coronary artery or microvascular  
     dysfunction 
 
“Syndrome X”  1) Includes classical syndrome X, microvascular angina,  
     coronary slow flow phenomenon 
    2) Characterized by prolonged episodes of exertional or  
     rest angina 
    3) Typically due to coronary microvascular dysfunction 
 
 
  
 A patient presenting with UA may progress to NSTEMI or even STEMI. Unstable 
angina may be classified depending on the severity and clinical circumstances. UA and 
NSTEMI are heterogeneous disorders in which patients have widely varying risk which is 
important in management decision. Table 2.2 shows the classification of unstable angina. 
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Table 2.2: Classification of Unstable Angina. Adapted from (Hamm and Braunwald, 2000) 
 Clinical Circumstances: 
 A 
Develops in presence 
of Extracardiac 
Condition That 
Intensifies 
Myocardial Ischaemia 
(Secondary UA) 
 
B 
Develops in Absence 
of Extracardiac 
Condition (Primary 
UA) 
C 
Develops Within 2 
weeks of AMI (Post-
infarction UA) 
Severity: 
 
I- New onset of severe 
angina or 
accelerated angina; 
no rest pain 
II- Angina at rest 
within past month 
but not within 
preceding 48h 
(angina at rest, 
subacute) 
II-Angina at rest 
within 48h (angina 
at rest, acute) 
 
 
 
IA 
 
 
 
IIA 
 
 
 
 
 
IIIA 
 
 
IB 
 
 
 
IIB 
 
 
 
 
 
IIIB-Tneg 
IIIB-Tpos 
 
 
IC 
 
 
 
IIC 
 
 
 
 
 
IIIC 
 
 
2.1.2 Non ST Elevation Myocardial Infarction (NSTEMI) and ST Elevation 
 Myocardial Infarction (STEMI) 
Acute myocardial infarction (AMI) can be defined based on clinical, ECG, biochemical, and 
pathological characteristics (Van de Werf et al., 2008). Clinically, AMI has been sub-
classified on the basis of the presenting ECG as either Non-ST-elevation myocardial 
infarction (NSTEMI) or ST elevation myocardial infarction (STEMI). The immediate clinical 
management differs so that it is important to differentiate these two forms of AMI. In 
NSTEMI, it does not require immediate intervention although early invasive therapy (at least 
within days) is preferred. In contrast with STEMI, immediate coronary reperfusion strategies 
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(either percutaneous coronary interventions or thrombolysis) on arrival to hospital are 
important in order to reduce the mortality (Beltrame et al., 2012). Table 2.3 shows the revised 
definition of myocardial infarction.  
 
Table 2.3: Revised Definition of Myocardial Infarction. Adapted from (Thygesen et al.,  
  2007) 
Criteria for acute, evolving or recent Myocardial Infarction 
Either one of the following satisfies the diagnosis for acute, evolving or recent Myocardial 
Infarction: 
1. Typical rise and / or fall in cardiac biomarkers (preferably troponin) with at least one 
of the following: 
- Ischaemia symptoms 
- Development of pathological Q waves in ECG 
- Electrocardiographic changes indicative of ischaemia (ST- segment 
elevation or depression) 
- Imaging evidence of new loss of viable myocardium or new regional wall 
motion abnormality 
2. Pathologic findings of an acute myocardial infarction 
 
Criteria for healing or healed Myocardial Infarction 
 
Either one of the following satisfies the diagnosis for healing or healed Myocardial 
Infarction: 
 
1. Development of new pathological Q waves with or without symptoms. Imaging 
evidence of a region of loss of viable myocardium that is thinned and fails to contract 
in the absence of a non-ischaemic cause 
2. Pathological findings of a healed or healing myocardial infarction 
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2.2 Burden of ACS 
The ACS are common causes of emergency hospital admission and major burden on health 
care resources in industrial countries (Fox et al., 2000). The World Health Organization 
(WHO) estimates CVD caused almost 32% of all deaths in women and 27% in men in 2004. 
In 2008, CAD is the most common cause of CVD deaths accounting for 7.25 million 
deaths/year, or 12.8% of all deaths worldwide. In many middle and high income countries, 
CAD is the single leading cause of death (WHO, 2012). In the United Kingdom (UK) in 
2008, CAD was responsible for about one in five male deaths and one in eight female deaths; 
a total of 88,000 CAD deaths (15% of total deaths) (BHF, 2010). Similarly in the United 
States (US) in 2005, CAD was responsible for one of every five deaths, accounting for 
445,687 deaths (18% of total deaths) (Lloyd-Jones et al., 2009). In Australia in 2006, CAD 
accounted for 22,983 deaths (17% of all deaths) and once more was the most common 
condition responsible for Australian (AIHW, 2010).  
 Trend of an increasing rate of CAD mortality noted in some developing countries. 
Developing countries contribute a major share to the global burden of cardiovascular disease. 
AMI remains one of the leading causes of death in the developing world as well as in the 
developed world (Abdallah et al., 2006). The WHO estimates that 60% of the global burden 
of CAD occurs in the developing countries. Although mortality estimates are difficult to 
obtain in some of these countries, broad assessments of overall CVD epidemiology report 
rising CVD mortality in urban China, Malaysia, Korea and Taiwan. In China, CVD mortality 
increased as a proportion of total deaths from 12.8% in 1957 to 35.8% in 1990 (Khor, 2001). 
The trend might be due to rapid urbanization, socioeconomic and health changes, together 
with an increase in life expectancy (Beltrame et al., 2012). 
 Based upon self-reported AMI in a UK national survey, the prevalence of AMI was 
reported as approximately 4.1% of men and 1.7% of women in 2006 (BHF, 2010). The 
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prevalence is age-dependent, extending from 1% of men less than 45 years of age to 17% of 
those more than 75 years old. Similarly, in the US, based upon national survey data available 
from the American Heart Association, the prevalence of AMI was 3.6% in 2006 (Lloyd-Jones 
et al., 2009). The prevalence was slightly higher in African American males (5.1%) 
compared with Caucasian males (4.9%) but lower in African American (2.2%) females 
compared with their Caucasian counterparts (3%). The prevalence of AMI was greater in the 
elderly compared with those less than 50 years of age as similar with UK population. In 
contrast, in developing countries such as South Asian countries (India, Pakistan, Bangladesh, 
Sri Lanka, and Nepal), the highest prevalence of AMI is seen in those younger than 40 years 
of age, whereas it is less marked in those older than 60 years (Joshi et al., 2007).  
 CVD remains an important cause of death in Malaysia accounting for 20-25% of all 
deaths in government hospitals from 2000- 2005. Following an AMI, the mortality rate was 
about 20% in 2004. This high rate could have been due to late presentation and diagnosis, 
leading to delayed treatment.  Occasionally the diagnosis could have been missed. In 2006, 
the estimated incidence of coronary disease in Malaysia was 141 per 100 000 populations. 
The in-patient mortality rate is approximately 7% (CPG, 2007a; Ahmad et al., 2011). 
Table 2.4: 10 Principles Cause of Death in Ministry of Health Malaysia (MOH) Hospitals, 
  2007.  
   Diseases                Percentage (%) 
1. Heart Diseases and Diseases of Pulmonary Circulation    16.49 
2. Septicaemia         13.38 
3. Malignant Neoplasms        11.28 
4. Cerebrovascular Diseases        8.50 
5. Pneumonia         7.43 
6. Accidents          5.20 
7. Diseases of the Digestive Systems      4.86 
8. Certain Conditions Originating in the Perinatal Period    4.11 
9. Nepthritis, Nephrotic Syndrome and Nephrosis     4.09 
10. Ill-define Conditions        2.55  
Source: Health Informatic Centre, Planning and Development Division, MOH, 2007 
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2.3 Burden of ACS in Young Patients 
Coronary heart disease (CHD) represents the leading cause of death in adults not only in 
western world but also worldwide. CHD may be manifest as myocardial infarction which is 
lethal and can be present as sudden death. Although myocardial infarction occurs mainly in 
older patients, however, 5 to 10% of cases occur in younger patients less than 45 years of age. 
If it occurs in young age, the disease causes a significant morbidity, psychological effects and 
financial constraints for the person and the family. The protective effect that offered by 
young age has been slowly taken away by the increased prevalence of risk factors for CHD in 
adolescents such as smoking, obesity and lack of activity. This will result in an increase 
disease burden in the near furture (Egred et al., 2005). 
 Although ACS in younger patients are generally associated with favorable prognosis, 
the personal and societal burden of premature coronary disease is substantial (Tungsubutra et 
al., 2007).  The young patient is of particular interest considering the years of potential life 
lost (Schoenenberger et al., 2011). 
  
2.4 History and Clinical Presentation of ACS  
Symptoms of ACS include chest pain, referred pain, nausea, vomiting, dyspnea, diaphoresis, 
and lightheadedness. Pain may be referred to the arm, jaw, neck, back, or even abdomen. 
Pain in which radiating to the shoulder, left arm, or both arms increases the likelihood of 
ACS (Goodacre et al., 2002). 
 Typical angina is described as substernal pain, occurs on exertion, and is relieved with 
rest. Patients with all three of these features have a greater likelihood of having ACS than 
patients with none, one, or even two of these features. However, some patients may present 
without chest pain or atypical symptoms and these do not necessarily rule out ACS. However, 
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a combination of atypical symptoms improves identification of low-risk patients (Achar et 
al., 2005).  
 The physical examination in patients with ACS is usually normal. Ominous physical 
findings include a new mitral regurgitation murmur, hypotension, pulmonary crackles, a new 
third heart sound (S3 gallop), and new jugular venous distention. Chest-wall tenderness 
reduces the likelihood of ACS (Goodacre et al., 2002).  
 
2.5 ECG Changes in ACS 
 The ECG provides information that assists in stratifying the patient’s risk of having ACS, 
establishing the diagnosis, and determining the treatment strategy. Accuracy of diagnosis is 
enhanced when the ECG is obtained in a patient with ongoing chest pain (Achar et al., 2005). 
 ECG changes of ST-segment elevation greater in lead III than in lead II with ST-
segment depression of more than 1mm in lead I, lead aVL or both showed involvement of 
right coronary artery. In left circumflex coronary artery involvement, the findings in ECG 
will be ST segment elevation in lead I, aVL, V5 and V6 and ST-segment depression in lead 
V1, V2 and V3. ST-segment elevation in leads V1, V2 and V3 with right bundle branch 
block and Q wave or both showed that proximal left anterior descending artery is infarcted. In 
proximal left anterior descending artery involvement, ECG changes will be ST-segment 
elevation in leads V1, V2 and V3 with ST-segment depression of more than 1mm in leads II, 
III and aVF while in distal left anterior descending artery involvement, there will be changes 
of ST-segment elevation in leads V1, V2 and V3 with ST-segment depression of < 1mm or 
ST-segment elevation in leads II, III and aVF (Zimetbaum and Josephson, 2003). 
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2.6 Biochemical Markers in ACS 
Creatine kinase (CK) is an enzyme that is not only found in striated muscle of the heart but 
also found in striated muscle and tissues of the brain, kidney, lung, and gastrointestinal tract. 
It is widely available marker but has low sensitivity and specificity for cardiac damage. 
Because it also can be found in other organ, CK levels may be elevated in a number of 
noncardiac conditions, including trauma, seizures, renal insufficiency, hyperthermia, and 
hyperthyroidism (Karras and Kane, 2001). A serum CK level may be used as a screening test 
to determine the need for more specific testing. The serum CK level rises within three to 
eight hours after myocardial injury, peaks by 12 to 24 hours, and returns to baseline within 
three to four days. Although CK commonly was measured serially, at the time of hospital 
admission and six to 12 hours after admission, this marker largely has been replaced by 
cardiac troponins and creatine kinase – myocardial band (CK-MB). CK-MB is much more 
cardiac specific than CK alone, and is useful for the early diagnosis of acute myocardial 
infarction (Braunwald et al., 2002).  
 CK-MB typically is detectable in the serum four to six hours after the onset of 
ischemia, peaks in 12 to 24 hours, and normalizes in two to three days. The CK-MB mass 
assay is more sensitive than the CK-MB activity assay. Like the CK level, the peak CK-MB 
level does not predict infarct size; however, it can be used to detect early reinfarction. Serial 
CK-MB levels commonly are obtained at admission to the emergency department and are 
repeated in six to 12 hours, depending on the assay that is used (Braunwald et al., 2002). 
 Troponins (T, I, C) are found in striated and cardiac muscle. Because the cardiac and 
skeletal muscle isoforms of troponin T and I differ, they are known as the “cardiac 
troponins.” They are the preferred markers for the diagnosis of myocardial injury. Troponin T 
and I generally have similar sensitivity and specificity for the detection of myocardial injury. 
Unlike troponin I levels, troponin T levels may be elevated in patients with renal disease, 
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polymyositis, or dermatomyositis. The cardiac troponins typically are measured at emergency 
department admission and repeated in six to 12 hours. Patients with a normal CK-MB level 
but elevated troponin levels are considered to have sustained minor myocardial damage or 
microinfarction, whereas patients with elevations of both CK-MB and troponins are 
considered to have had AMI. The cardiac troponins may remain elevated up to two weeks 
after symptom onset, which makes them useful as late markers of recent AMI (Braunwald et 
al., 2002; Achar et al., 2005). 
 The Joint European Society of Cardiology/American College of Cardiology 
Committee for the Redefinition of Myocardial Infarction emphasized the use of troponins as 
critical markers of the presence of myocardial necrosis (Antman et al., 2000). Although 
troponins are accurate in identifying myocardial necrosis, the latter is not always secondary to 
atherosclerotic coronary artery disease. Therefore, in establishing the diagnosis of NSTEMI, 
cardiac troponins should be used in conjunction with appropriate clinical features and 
electrocardiographic changes. Myocardial injury of diverse origins (e.g., myocarditis, trauma, 
or cardioversion) may cause necrosis and release of troponins. Although these may be 
considered instances of NSTEMI, they should be distinguished on clinical grounds from the 
more common form of NSTEMI secondary to coronary atherosclerosis (Braunwald et al., 
2002). 
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2.7 Risk Factors of ACS 
2.7.1 Sociodemographic Characteristics 
The Global Registry of Acute Coronary Events (GRACE) reported that the mean age of AMI 
patients in developing countries ranges from 55 to 65 years, which is lower than in the 
developed world (65 to 68 years) (Fox et al., 2000; Abdallah et al., 2006).  The European 
Network for Acute Coronary Treatment (ENACT) study showed that the mean age of 
unstable angina was 65.2 years and myocardial infarction was 63.8 years and overall, 30% of 
patients from the study were female (Fox et al., 2000). In young population, 5.8% patients 
were less than 45 years old and the youngest patient in the study was 22.8 years old as 
reported from the Thai ACS registry (Tungsubutra et al., 2007). In Malaysia, from National 
Cardiovascular Disease Database (NCVD)-ACS Registry, the mean (standard deviation (SD)) 
age for all subjects was 59 (12) years which was significantly younger than that of GRACE 
and other ACS registries. And for STEMI, NSTEMI and UA patients, mean age were 56, 62 
and 60 years respectively. Male to female ratio was 3:1. The highest incidence of ACS for 
men was in 50–60 year age group and for women in 70–80 years group. The proportion of 
Malay, Chinese, Indian and other races contributed 49%, 23%, 23% and 5% respectively 
(Ahmad et al., 2011). CAD is the leading cause of mortality for both adult males and females 
alike worldwide. Although the initial manifestation of CAD is delayed in females by about 
ten years compared to males, there is not an abrupt increase in CAD mortality rates for 
females immediately following menopause but a progressive increase over subsequent years 
(Beltrame et al., 2012).  
 Socioeconomic status (SES) indicators, including education, income and occupation, 
are associated with CAD risk factors, morbidity, and mortality. Patients with less education, 
lower income, and blue-collar occupations are associated with increased rates of CAD and 
increased risk of CAD mortality. Correspondingly, lower SES groups also have the least 
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favourable lifestyle characteristics, including obesity, smoking, high cholesterol, 
hypertension, and lack of physical activity. The British Heart Foundation (BHF) reports a 
clear gradient in CAD mortality across low to high SES group. The inequality is more 
striking in females than males, with the CAD death rate being five times higher in female 
blue-collar workers compared to females in professional occupations (Beltrame et al., 2012).  
 
2.7.2 Clinical Presentation 
The symptoms of UA/NSTEMI may be indistinguishable from that of STEMI. Chest pain is 
the presenting symptom in most patients. Chest pain was the most frequent symptoms during 
hospital admission in young patients with 9 of 10 patients having chest pain (Schoenenberger 
et al., 2011). Chest pain or discomfort is usually retrosternal, central or in the left chest and 
may radiate to the jaw or down the upper limb. It may be crushing, pressing or burning in 
nature and the severity of the pain is variable. A significant number of patients, especially 
women, diabetics and the elderly, presented with atypical symptoms. These include; 
dyspnoea without any history of chest pains, unexplained sweating, nausea and vomiting, 
syncope and presyncope, fatigue and epigastric discomfort. In patients with these 
presentation(s) and with a prior history of CAD, a family history of premature CVD, diabetes 
and other cardiovascular risk factors, the index of suspicion of ACS should be high. Prior 
history of diabetes and renal disease will influence management (CPG, 2011). 
 Dyspnea and sign of heart failure were less common in younger patients. The Killip 
classification is a system used in individuals with an ACS, for risk stratification.  Patients 
were classified into four classes during physical examination. Patients in Class I 
demonstrated no evidence of heart failure. Patients in Class II had findings consistent with 
mild to moderate heart failure; patients in Class III demonstrated overt pulmonary edema and 
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patients in Class IV were in cardiogenic shock. Only few young patients (5.7%) presented 
with Killip class II or higher (Schoenenberger et al., 2011). The proportion presenting 
presenting with heart failure (Killip class 3-4) increased markedly with age (Rosengren et al., 
2006).  In NCVD-ACS, 76% of STEMI patients were in class I and II, 9% were in class III 
and IV (Ahmad et al., 2011). Table 2.4 showed the clinical and haemodynamic subsets of 
AMI. The 30-day mortality was only 7% in Killip Class I and markedly increased to 70% in 
Killip Class IV (CPG, 2007a). Presence of left ventricular failure (hypotension, respiratory 
crackles or S3 gallop) and arrhythmias carry a poor prognosis. Carotid bruits or peripheral 
vascular disease indicates extensive atherosclerosis and a higher likelihood of concomitant 
CAD. Table 2.4 shows the clinical and haemodynamic subsets in AMI.  
 
Table 2.5: Clinical and Haemodynamic Subsets in AMI. Adapted from (CPG, 2007a) 
Killip’s 
Classification 
 
Clinical Features 
 
Approximate 
proportion of 
patients with AMI 
(%) 
30 day - Mortality 
(%) 
 
I 
 
No signs of LV 
failure 
71.0 7 
II 
 
S3 gallop, bibasal 
crackles 
23.0 
 
20 
 
III 
 
Acute pulmonary 
oedema 
3.7 
 
39 
 
IV 
 
Cardiogenic shock 2.3 70 
  
 For type of ACS, younger patients frequently presented with STEMI (73.1%) 
(Schoenenberger et al., 2011). Similarly in Thai registry, younger patients were likely to have 
an STEMI, 67.3% (Tungsubutra et al., 2007).  
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2.7.3 Smoking 
According to the INTERHEART study, smoking was the most important risk factor for AMI 
globally (Abdallah et al., 2006). From ‘‘The Atlas of Heart Disease and Stroke” by WHO, 
the prevalence of smoking among ACS patients were 12% and it was one of the contribution 
of the classical CAD risk factors to the overall burden of disease in developing countries 
(WHO, 2012). While in ENACT study showed smoking among UA was 35% while among 
MI was 46% (Fox et al., 2000). The prevalence of smoking has been shown to be 
increasingly prevalence in young adults and adolescents reaching up to 9% (Egred et al., 
2005). Smoking was the most prevalent cardiovascular risk factors in young patients with 3 
of 4 young patients being current smoker (Schoenenberger et al., 2011). This was similar 
finding in Thailand when 66% of patients age less than 45 years were smokers (Tungsubutra 
et al., 2007). Considering smoking habit, 33% of entire cohort and 50% of STEMI population 
were active smokers and 24% of entire cohort was ex-smokers were found from NCVD-ACS 
Registry (Ahmad et al., 2011). 
 
2.7.4 Dyslipidaemia  
The INTERHEART Study revealed that hypercholesterolemia (high ApoB/ApoA levels) is a 
significant risk factor for AMI in Southeast Asia (Yusuf et al., 2004). The  ENACT study 
showed that dyslipidaemia among UA was 31% while among MI was 20% (Fox et al., 2000). 
There were 55.9% subjects in the NCVD-ACS registry diagnosed with dyslipidaemia, while 
43.6% from GRACE registry (Ahmad et al., 2011).   
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2.7.5 Diabetes mellitus   
The ENACT study showed diabetes mellitus among UA was 23% while among MI was 19% 
(Fox et al., 2000). The Malaysia NCVD-ACS registry showed that 55% of ACS had 
underlying diabetes mellitus (Ahmad et al., 2011). 
 
2.7.6 Hypertension 
The ENACT study showed that hypertension among UA was 51% while in MI was 41% (Fox 
et al., 2000). Hypertension was the most prevalent cardiovascular risk factor, present in 
72.6% subjects in the Malaysia NCVD-ACS registry, higher as compared to 57.8% from the 
GRACE study (Ahmad et al., 2011).   
 
2.7.7 Obesity 
In other hand, obesity also has emerged as a major risk factor for CAD in the recent years. In 
the developing world, it was estimated that one third of the population were obese. The risk 
of developing CAD in obese patients was estimated to be about three times more than in 
those with normal body weight (Abdallah et al., 2006). Obesity is a growing concern among 
young adults and children and it has increased by threefold in the UK in the past two decades. 
Insulin resistance, which by itself is a marker for CHD, has been found among 24% of school 
children in USA. Metabolic syndrome and insulin resistance were found in two thirds of 
young people with MI (Egred et al., 2005) 
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2.7.8 Family History of CAD 
Younger patients have a higher prevalence of a positive family history. In the Thai Registry, 
23.6% of patients had family history of coronary (Tungsubutra et al., 2007) while in the 
Malaysia NCVD-ACS registry, 19.7% had a positive family history (Ahmad et al., 2011). 
 
2.8 Management of ACS 
2.8.1 Pharmacology 
The primary modality for opening up occluded arteries in AMI remains thrombolysis in 
developing as well as developed countries. Many developing countries are not able to provide 
enough cardiac catheterization laboratories to support programs for primary angioplasty as a 
primary modality of treatment for AMI. This is the reason for the use of thrombolytic therapy 
as a mainstay of treatment for STEMI in these countries and it is higher than what is reported 
in developed countries (Abdallah et al., 2006). 
 In the ENACT study, a high proportion of AMI patients received thrombolytic 
therapy; 51% by initial diagnosis (upon arrival in hospital) and 43% by final diagnosis 
(during admission with complete investigations). Most patients received aspirin (96%), 
nitrates (80%) and some form of heparin (90%). There was wide variation in the use of 
calcium antagonists, beta-blockers, low-molecular–weight heparin and glycoprotein IIb/ III1 
inhibitors. Overall use of low molecular weight heparin was 34% in AMI. (Fox et al., 2000). 
 In Malaysia, 70% received fibrinolytic therapy among STEMI patients. Reasons for 
not receiving fibrinolytic therapy included primary percutaneous coronary intervention (PCI) 
in 8%, presentation after more than 12 hours in 13%, contraindications to streptokinase in 
5%, the remaining 3% included missing data and refusal to treatment. Streptokinase was 
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solely used as fibrinolytic agent. Aspirin and statins were prescribed in more than 90%, beta 
blocker in 66%, clopidogrel in 59%, ACE-I in 58% and LMWH in 51% and GP receptor 
inhibitor in 4% of all patients. Prescription rate for LMWH in NSTEMI and UA patients were 
68% and 64% respectively (Ahmad et al., 2011). 
 Patients less than 45 years old were likely to received aspirin, thienopyridine, GP IIb/ 
IIIa antagonist, beta blocker and statins, whereas they were less likely to received nitrates and 
calcium channel blocker. Young patients with STEMI tended to received fibrinolytic therapy 
(Tungsubutra et al., 2007). Younger patients seem to tolerate the thrombolytic agents better 
with a good ST segment resolution in the ECG (Egred et al., 2005) 
 
2.8.2 Surgical Intervention 
From the ENACT study, 41% of UA patients underwent coronary angiography and 23% of 
UA patients underwent percutaneous coronary intervention (PCI). For AMI patients, 33% of 
patients underwent angiography and 23% underwent PCI (Fox et al., 2000). 
 In Malaysia, based on NCVD-ACS registry, coronary angiography was performed in 
35% of all patients during the hospital admission and out of those who had angiography, 46% 
had PCI. Among those who had PCI, 56% belonged to STEMI, 30% belonged to NSTEMI 
and 14% belonged to UA group. Coronary Artery Bypass Graft Surgery (CABG) was 
performed only in 0.02%. Majority of NSTEMI and UA patients were treated medically 
while PCI was done in 14% and 9% respectively (Ahmad et al., 2011). 
   The proportion of patients undergoing a coronary angiography decreased with age 
(Rosengren et al., 2006). From the Thai registry, coronary angiography and PCI were 
performed more frequently in patients aged less than 45 years old. Young patients with 
STEMI tended to received primary PCI (Tungsubutra et al., 2007). PCI in older patients were 
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associated with procedural complications such as myocardial infarction rate of 5%, urgent 
coronary artery bypass grafting (CABG) of 1% and mortality of 1%. The success rate of 
percutaneous procedures was higher in younger patients approaching 93%. CABG carries a 
better success rate in younger patients. Survival rate were found to be 92% at five years and 
86% in 10 years respectively in patients less than 40 years, compared with 75% and 58% for 
patients over 65 years old (Egred et al., 2005). 
 Young patients showed less diffuse atherosclerotic lesions as compared to patients of 
the older group: in young patients, 75% showed one-vessel CAD and 23.2% two- or three- 
vessel CAD. The proportion of young patients with normal coronary arteries was 1.8%. 
(Schoenenberger et al., 2011). 
 
2.9 Complications of ACS 
In-hospital complications of AMI patients has steadily decline over the last several decade to 
less than 10% (Rogers et al., 2000). This remarkable achievement is due to the development 
of rapid pharmacologic and mechanical reperfusion and adjunctive pharmacotherapy. The 
development of rapid cardiac referral networks and coronary care units also contributed to the 
decline. Despite of medical advances, AMI remains a life threatening illness and physician 
should always be aware of possible complications. Likewise, newer therapies for ACS such 
as PCI have come increasingly complex and inherently carry their own risk of complications 
(Pattanayak and Gelfand, 2009). 
 IHD was the predominant cause of congestive heart failure (CHF), accounting for 
49.5% (Chong et al., 2003). Patients aged less than 45 years old had the lowest incidence of 
heart failure as the incidence increased with increasing age (Tungsubutra et al., 2007). Heart 
failure increasingly with age in which 10.2% in men and 11.3% in women of young patients 
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(Rosengren et al., 2006).  Pulmonary oedema was reported about 2.3% in men and 4.2% in 
women of young patients with ACS (Rosengren et al., 2006). 
 Bradycardia and heart block following an ACS typically occur either because of 
exaggerated vagal tone, or due to the ischemia/infarction of the actual conduction tissue. 
Sinus bradycardia and varying degrees of AV block are often seen in inferior and posterior 
MI due to increased vagal tone. On the other hand, in anterior MI conduction disturbances are 
caused by necrosis of the bundle of His and its branches. Sinus bradycardia and AV block 
may be observed in the early period of an inferior myocardial infarction. These vagally 
mediated bradycardias are often transient, and initially tend to respond to anticholinergic 
action of atropine. In the 24 to 72 hours following symptom onset, AV conduction delay may 
be caused by tissue edema (in addition to vagal tone) and is therefore less responsive to 
atropine. Second-degree heart block can occur either at the level of the AV node or below the 
node at the level of the His bundle (Pattanayak and Gelfand, 2009). 
 Atrial fibrillation is a common arrhythmia during and immediately following STEMI, 
occurring about 5–10% of the time. This is because many of the risk factors for STEMI, such 
as hypertension, obesity, and diabetes, are also the substrate for atrial fibrillation. 
Furthermore, the high catecholamine state and elevation of left atrial pressure in STEMI act 
as triggers for atrial fibrillation. An important consideration in atrial fibrillation is that rapid 
heart rates can increase myocardial ischemia and decrease cardiac output, thereby making 
early cardioversion a possible option (Pattanayak and Gelfand, 2009). Atrial fibrillation 
occurred in few of the youngest patients, 2.7% (Rosengren et al., 2006). 
 Ventricular tachyarrhythmias occurring during and early following acute MI are the 
leading cause of death in ACS prior to hospital presentation. Sustained ventricular 
tachycardia (VT) and ventricular fibrillation (VF) complicate 10% of STEMI and 2.5% of 
NSTEMI presentation, with the majority occurring in the first 48 hours (Pattanayak and 
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Gelfand, 2009).  Patients with sustained VT are frequently symptomatic as consequence of 
both from hemodynamic effects of AV dissociation and from inefficient left ventricular (LV) 
contraction, and therefore immediate therapy with synchronized cardioversion is required. 
Patients with well-tolerated sustained VT may be treated pharmacologically. Many deaths 
occur in the very first hours after STEMI due to ventricular fibrillation (VF) (Van de Werf et 
al., 2008). 
 Cardiogenic shock due to pump failure remains the most common cause of in-hospital 
complications with patients diagnosed with ACS. Data from the Global Use of Strategies to 
Open Occluded Coronary Arteries in Acute Coronary Syndromes (GUSTO)-IIb trial suggest 
that cardiogenic shock complicates approximately 4% of acute STEMI and 2.5% of NSTEMI 
cases (Holmes Jr et al., 1999). Overall about 2% of ACS patients are in shock upon hospital 
presentation. Despite primary reperfusion and adjunctive medical therapy, cardiogenic shock 
can develop in some patients in the hospital. As ACS therapy advanced in the last 10 years, 
the rate of in-hospital cardiogenic shock fell by approximately 75% (from 10.6% to 2.7%) 
(Jeger et al., 2008). The etiology of shock usually progressive infarction of the LV. The 
cardiogenic shock was increasingly with age in which 3% of young men and 4.7% of young 
women patients had shock during their hospital admission (Rosengren et al., 2006). 
 Recurrent ischaemia and reinfarction increased only slightly with age in men and not 
all in women. In young patients, men had 10.6% and women had 13.6% of recurrent 
ischaemia and for reinfarction, men had 1.3% and women had 2.5% (Rosengren et al., 2006). 
 In-hospital mortality was lower in the younger group, 7.4% compared to elder group 
of more than 54 years old, 14.1% (Tungsubutra et al., 2007). Outcome was excellent in 
young patients, only 1.5% died during the hospitalization in Switzerland (Schoenenberger et 
al., 2011). Overall, the in-hospital death increased from 1% among patients less than 55 years 
to 17% in patients more than 85 years (Rosengren et al., 2006). By NCVD-ACS registry, the 
